
Sandvik signed an agreement to divest its Additive Manufacturing (AM) business unit to Mimir, a global investment firm based in Sweden. The transaction is expected to close in 3Q26.
The AM unit manufactures metal powders used in areas such as additive manufacturing, metal injection molding and hot isostatic pressing. For instance, Osprey Ti-6Al-4V-ELI (Grade 23) is typically used for medical implants as well as for aerospace and chemical processing applications.
Sandvik continuously evaluates its portfolio to assess criteria such as market position, profitable growth potential and investment needs, and based on this evaluation process, the decision to divest Additive Manufacturing was made.
As a standalone company focused on gas-atomized metal powders, Osprey intends to intensify its investment in product development, new alloys and international market expansion — with particular focus on additive manufacturing and other advanced processes with fast-growing demand. The acquisition aligns with Mimir’s strategy of carving divisions and business areas out from global groups and unlocking their potential as focused, high-technology companies.
“This divestment is intended to better position the Additive Manufacturing business for its next growth phase, and we believe the new owner will provide the platform and dedicated focus needed to further develop the business towards its full potential,” said Stefan Widing, President and CEO of Sandvik.
Joakim Notö, Managing Partner at Mimir, said, “Osprey…combines deep materials science, a world-class alloy library and decades-long customer relationships in markets with strong underlying growth. That combination creates barriers to entry that are very hard to build and even harder to copy — and that is where we see the potential to accelerate value creation.”
Sources: Sandvik AB; Mimir
JAV
Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



